A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
Clinical trial NCT02969369 · COMPLETED
Trial details
- NCT number
- NCT02969369
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-31
- Primary completion
- 2020-04-20
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.